Twist Bioscience

Twist Bioscience, founded in 2013, is a prominent synthetic biology firm specializing in high-precision, large-scale synthetic DNA manufacturing. Utilizing a proprietary silicon-based technology platform, the company provides critical solutions for life sciences, medicine, agriculture, and industrial biotechnology. Their product suite includes next-generation sequencing (NGS) target enrichment panels, custom DNA libraries, and antibody discovery tools, enabling researchers to accelerate innovation in genetic research and drug development.

Operating with 500-1,000 employees, Twist Bioscience maintains a robust operational footprint to support its global client base. The company is headquartered in South San Francisco, California, where it manages its primary manufacturing and research facilities. Learn about Twist Bioscience's global headquarters for more information regarding their geographic presence and infrastructure. The firm’s commitment to high-quality, scalable DNA production has established it as a key player in the biotechnology sector, competing with entities like Ginkgo Bioworks and Integrated DNA Technologies.

Listed on the NASDAQ under the ticker TWST, the company demonstrates significant market activity and consistent growth. With annual revenue reaching $409.5M, Twist Bioscience continues to expand its influence in the pharmaceutical and healthcare industries. Meet Twist Bioscience's team to learn about the leadership driving these advancements, or Explore financial highlights for detailed metrics on their funding history and fiscal performance. The company’s strategic focus on end-to-end genomic solutions remains central to its long-term growth trajectory.